These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13346364)

  • 1. An attempt to demonstrate a catatonigenic agent in cerebrospinal fluid of catatonic schizophrenic patients.
    SHAPIRO AK
    J Nerv Ment Dis; 1956 Jan; 123(1):65-71. PubMed ID: 13346364
    [No Abstract]   [Full Text] [Related]  

  • 2. The schizophrenic patients with an increase of the protein content of the cerebrospinal fluid.
    BRUETSCH WL
    Am J Psychiatry; 1958 Dec; 115(6):545. PubMed ID: 13595132
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of tri-iodothyronine on abnormalities in the cerebrospinal fluid of chronic schizophrenic patients.
    SIMPSON GM; HARRIS AH
    Am J Psychiatry; 1962 Aug; 119():170-1. PubMed ID: 13913211
    [No Abstract]   [Full Text] [Related]  

  • 4. [RELATIONSHIP OF AMENTIVE AND CATATONIC STATES OF STAUDER TYPE TO THE SCHIZOPHRENIC PSYCHOSIS IN THE LIGHT OF A FOLLOW-UP STUDY OF 55 CASES].
    LASKOWSKA D; URBANIAK K; JUS A
    Neurol Neurochir Psychiatr Pol; 1964; 14():575-80. PubMed ID: 14249539
    [No Abstract]   [Full Text] [Related]  

  • 5. [Electrophoresis of cerebrospinal protein bodies in schizophrenic diseases].
    HABECK D
    Nervenarzt; 1959 Sep; 30():396-400. PubMed ID: 13830639
    [No Abstract]   [Full Text] [Related]  

  • 6. Paper-electrophoretic studies of cerebrospinal-fluid (CSF)-proteins of neuropsychopathic patients. I. On the CSF-proteins of the schizophrenic patients.
    ISHII A
    Folia Psychiatr Neurol Jpn; 1958 Mar; 11(4):364-9. PubMed ID: 13574272
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebrospinal fluid neuraminic acid deficiency in schizophrenia.
    BOGOCH S
    AMA Arch Neurol Psychiatry; 1958 Aug; 80(2):221-7. PubMed ID: 13558776
    [No Abstract]   [Full Text] [Related]  

  • 8. [Catatonia: resurgence of a concept. A review of the international literature].
    Pommepuy N; Januel D
    Encephale; 2002; 28(6 Pt 1):481-92. PubMed ID: 12506260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on N-acetyl neuraminic acid in the cerebrospinal fluid in schizophrenia.
    ROBINS E; CRONINGER AB; SMITH K; MOODY AC
    Ann N Y Acad Sci; 1962 Jan; 96():390-1. PubMed ID: 14492876
    [No Abstract]   [Full Text] [Related]  

  • 10. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'). II. Factor analysis of the catatonic syndrome.
    Ungvari GS; Goggins W; Leung SK; Gerevich J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):462-8. PubMed ID: 17188791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia with prominent catatonic features: A selective review.
    Ungvari GS; Gerevich J; Takács R; Gazdag G
    Schizophr Res; 2018 Oct; 200():77-84. PubMed ID: 28818505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenaline and noradrenaline in cerebrospinal fluid.
    WEIL-MALHERBE H; LIDDELL DW
    J Neurol Neurosurg Psychiatry; 1954 Nov; 17(4):247-9. PubMed ID: 13212413
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some data on the chemistry of cerebrospinal fluid in the pathomechanism, diagnosis and prognosis of schizophrenia].
    HERMANN B; SOOKY A; CSEPPENTO I; DOBI S
    Orv Hetil; 1959 Sep; 100():1332-6. PubMed ID: 13852247
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebrospinal fluid creatine kinase in acutely psychotic patients.
    Martin WA; Garey RE; Heath RG
    J Neurol Neurosurg Psychiatry; 1972 Oct; 35(5):726-9. PubMed ID: 5084141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
    Jiang L; Lindpaintner K; Li HF; Gu NF; Langen H; He L; Fountoulakis M
    Amino Acids; 2003 Jul; 25(1):49-57. PubMed ID: 12836058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal cerebrospinal fluid proteins in schizophrenia].
    Sizaret P; Degiovanni A; Martin JC
    Ann Med Psychol (Paris); 1972 Nov; 2(4):507-13. PubMed ID: 4120433
    [No Abstract]   [Full Text] [Related]  

  • 17. Nucleases in the cerebrospinal fluid. II. Desoxyribonuclease in health and disease.
    KOVACS E
    J Pediatr; 1954 Nov; 45(5):569-74. PubMed ID: 13212597
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigation on the inoculation of biological materials from schizophrenic patients in chick embryos, in guinea pigs, in white mice and in monkey kidney tissue culture.
    MASTROGIOVANNI PD
    Confin Neurol; 1958; 18(2-4):112-4. PubMed ID: 13597482
    [No Abstract]   [Full Text] [Related]  

  • 19. Myelin basic protein antibodies in catatonic schizophrenia.
    Rimón R; Ahokas A; Ruutiainen J; Halonen P
    J Clin Psychiatry; 1986 Jan; 47(1):26-8. PubMed ID: 2416737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cephalin-cholesterol test (Hanger reaction) applied to the cerebrospinal fluid of schizophrenics].
    GIOVANNELLI G
    Rass Studi Psichiatr; 1955; 44(3):391-6. PubMed ID: 13255078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.